
Novo Nordisk President and CEO Mike Doustdar Talks Wegovy Pill
Bloomberg Talks
00:00
Competing with Lilly's oral GLP-1
Katie questions competition; Mike contrasts phase‑three data and efficacy parity with injections.
Play episode from 01:54
Transcript


